WHO ICTRP trial
Study of efficacy and safety of reduced chemotherapy and risk evaluation of…
JPRN-UMIN000026100 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000026100 |
|---|---|
| Public title | Study of efficacy and safety of reduced chemotherapy and risk evaluation of perforation by Endoscopy for gastrointestinal non-Hodgkin Lymphoma |
| Scientific title | Study of efficacy and safety of reduced chemotherapy and risk evaluation of perforation by Endoscopy for gastrointestinal non-Hodgkin Lymphoma - Study of efficacy and safety of reduced chemotherapy and risk evaluation of perforation by Endoscopy for gastrointestinal non-Hodgkin Lymphoma |
| Primary sponsor | Gifu University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Gastrointestinal non-Hodgkin lymphoma |
| Interventions | Cyclophosphamide 525mg/m2 DIV Day1 Adriamycin or Therarubicin 35mg/m2 DIV Day1 Vincristine 1mg/m2(max 2mg)DIV Day1 Prednisolone Oral 100mg/body Day1-5 Rituximab DIV 375mg/m2 Day0 |
| Registration date | Dec 2, 2017 |
| Target size | 40 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: